Skip to main content
. 2019 Jan 28;4(5):656–666. doi: 10.1016/j.ekir.2019.01.014

Table 1.

Baseline characteristics of the KT recipients older than 70 years (n = 171)

Recipient All Death <1 yr (n = 17)
Age, yr (mean ± SD) 73.3 ± 2.5 74.0 ± 2.6
 Range, yr 70.0–82.4 70.0–78.5
Male, n (%) 116 (67.8) 12 (70.6)
BMI, kg/m2 (mean ± SD) 25.5 ± 3.4 23.8 ± 1.9
Primary renal disease, n (%)
 Diabetes 28 (16.4) 2 (11.8)
 Vascular 27 (15.8) 7 (41.2)
 Interstitial 19 (11.1) 2 (11.8)
 Glomerular 25 (14.6) 1 (5.9)
 Polycystic 23 (13.5) 2 (11.8)
 Unknown 34 (19.9) 2 (11.8)
Mode of dialysis, n (%)
 Preemptive transplant 24 (14) 0 (0)
 Hemodialysis 123 (72.8) 15 (88.2)
 Peritoneal dialysis 22 (13) 2 (11.8)
Time on dialysis before transplant, yr (mean ± SD) 2.7 ± 2.5 3.9 ± 2.8
Waiting time, yr (mean ± SD) 0.97 ± 0.97 1.2 ± 0.9
HLA antibodies, n (%) 38 (22.2) 6 (35.3)
Comorbidities, n (%)
 Hypertension 159 (95.2) 16 (94.1)
 Diabetes 40 (23.9) 3 (17.6)
 Coronary artery disease 35 (20.9) 6 (35.3)
 Cardiomyopathy 72 (43.1) 10 (58.8)
 Peripheral vascular disease 24 (14.1) 3 (17.6)
 Arrhythmia 28 (16.8) 5 (29.4)
Plasma albumin (g/L) 39.7 ± 4.6 40 ± 0.5
Donor
Deceased donor, n (%) 168 (98.2) 17 (100)
 Deceased from cardiovascular cause 121 (72.9) 15 (88.2)
Age, yr (mean ± SD) 70.1 ± 10.5 70 ± 7.5
Transplantation characteristics
Cold ischemic time, h (mean ± SD) 17.8 ± 5 17.3 ± 2.6
Delayed graft function, n (%) 48 (30.6) 3 (17.6)
Initial hospitalization duration 22.3 ± 22 31.1 ± 32
 Range, d 3–173 4–140

BMI, body mass index; HLA, human leucocyte antigen; KT, kidney transplant.